|
|
Prepublished online as a Blood First Edition Paper on April 24, 2003; DOI 10.1182/blood-2003-02-0488.
Previous Article | Table of Contents | Next Article 
Blood, 15 August 2003, Vol. 102, No. 4, pp. 1169-1177
CHEMOKINES
RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement
Branka Roscic-Mrkic,
Marek Fischer,
Christine Leemann,
Amapola Manrique,
Cynthia J. Gordon,
John P. Moore,
Amanda E. I. Proudfoot, and
Alexandra Trkola
From the Division of Infectious Diseases, Department of Medicine, University Hospital, Zurich, Switzerland; Department of Pathology, New York University School of Medicine, New York; Weill Medical College of Cornell University, Department of Microbiology and Immunology, New York, NY; and Serono Pharmaceutical Research Institute, Geneva, Switzerland.
The CC-chemokine RANTES (regulated on activation normal T-cell expressed and secreted; CCL5) transduces multiple intracellular signals. Like all chemokines, it stimulates G proteincoupled receptor (GPCR) activity through interaction with its cognate chemokine receptor(s), but in addition also activates a GPCR-independent signaling pathway. Here, we show that the latter pathway is mediated by an interaction between RANTES and glycosaminoglycan chains of CD44. We provide evidence that this association, at both low, physiologically relevant, and higher, probably supraphysiologic concentrations of RANTES, induces the formation of a signaling complex composed of CD44, src kinases, and adapter molecules. This triggers the activation of the p44/42 mitogen-activated protein kinase (MAPK) pathway. By specifically reducing CD44 expression using RNA interference we were able to demonstrate that the p44/p42 MAPK activation by RANTES requires a high level of CD44 expression. As well as potently inhibiting the entry of CCR5 using HIV-1 strains, RANTES can enhance HIV-1 infectivity under certain experimental conditions. This enhancement process depends in part on the activation of p44/p42 MAPK. Here we show that silencing of CD44 in HeLa-CD4 cells prevents the activation of p44/p42 MAPK and leads to a substantial reduction in HIV-1 infectivity enhancement by RANTES.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Gaertner, F. Cerini, J.-M. Escola, G. Kuenzi, A. Melotti, R. Offord, I. Rossitto-Borlat, R. Nedellec, J. Salkowitz, G. Gorochov, et al.
Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide
PNAS,
November 18, 2008;
105(46):
17706 - 17711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Huber, V. von Wyl, C. G. Ammann, H. Kuster, G. Stiegler, H. Katinger, R. Weber, M. Fischer, H. Stoiber, H. F. Gunthard, et al.
Potent Human Immunodeficiency Virus-Neutralizing and Complement Lysis Activities of Antibodies Are Not Obligatorily Linked
J. Virol.,
April 15, 2008;
82(8):
3834 - 3842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zernecke, J. Bernhagen, and C. Weber
Macrophage Migration Inhibitory Factor in Cardiovascular Disease
Circulation,
March 25, 2008;
117(12):
1594 - 1602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Borg and M. Holland
The effect of glycosaminoglycans on rat gametes in vitro and the associated signal pathway
Reproduction,
March 1, 2008;
135(3):
311 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sutton, V. Friand, D. Papy-Garcia, M. Dagouassat, L. Martin, R. Vassy, O. Haddad, O. Sainte-Catherine, M. Kraemer, L. Saffar, et al.
Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells
Mol. Cancer Ther.,
November 1, 2007;
6(11):
2948 - 2958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zoller, P. Gupta, R. Marhaba, M. Vitacolonna, and P. Freyschmidt-Paul
Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases
J. Leukoc. Biol.,
July 1, 2007;
82(1):
57 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pakula, A. Melchior, A. Denys, C. Vanpouille, J. Mazurier, and F. Allain
Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis
Glycobiology,
May 1, 2007;
17(5):
492 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tzircotis, R. F. Thorne, and C. M. Isacke
Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding
J. Cell Sci.,
November 1, 2005;
118(21):
5119 - 5128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rusert, H. Kuster, B. Joos, B. Misselwitz, C. Gujer, C. Leemann, M. Fischer, G. Stiegler, H. Katinger, W. C. Olson, et al.
Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors
J. Virol.,
July 1, 2005;
79(13):
8454 - 8469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Charnaux, S. Brule, T. Chaigneau, L. Saffar, A. Sutton, M. Hamon, C. Prost, N. Lievre, C. Vita, and L. Gattegno
RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44
Glycobiology,
February 1, 2005;
15(2):
119 - 130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wilflingseder, B. Mullauer, H. Schramek, Z. Banki, M. Pruenster, M. P. Dierich, and H. Stoiber
HIV-1-Induced Migration of Monocyte-Derived Dendritic Cells Is Associated with Differential Activation of MAPK Pathways
J. Immunol.,
December 15, 2004;
173(12):
7497 - 7505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Skwor, H. Cho, C. Cassidy, T. Yoshimura, and D. N. McMurray
Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages
J. Leukoc. Biol.,
December 1, 2004;
76(6):
1229 - 1239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Lau, C. D. Paavola, Z. Johnson, J.-P. Gaudry, E. Geretti, F. Borlat, A. J. Kungl, A. E. Proudfoot, and T. M. Handel
Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1: IMPLICATIONS FOR STRUCTURE AND FUNCTION IN VIVO
J. Biol. Chem.,
May 21, 2004;
279(21):
22294 - 22305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Thorne, J. W. Legg, and C. M. Isacke
The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events
J. Cell Sci.,
January 22, 2004;
117(3):
373 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Atamas, I. G. Luzina, J. Choi, N. Tsymbalyuk, N. H. Carbonetti, I. S. Singh, M. Trojanowska, S. A. Jimenez, and B. White
Pulmonary and Activation-Regulated Chemokine Stimulates Collagen Production in Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol.,
December 1, 2003;
29(6):
743 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|